We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
+15.35%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.04B
AUM Growth
+$121M
(+6.3%)
Cap. Flow
-$60.1M
Cap. Flow
% of AUM
-2.95%
Top 10 Holdings %
Top 10 Hldgs %
32.32%
Holding
334
New
52
Increased
46
Reduced
60
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$45M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$23.9M |
| 3 |
Nike
NKE
|
+$22.3M |
| 4 |
Stryker
SYK
|
+$20.4M |
| 5 |
NVIDIA
NVDA
|
+$19.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$37.2M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$21.8M |
| 3 |
iShares Russell 2000 Value ETF
IWN
|
+$20.7M |
| 4 |
lululemon athletica
LULU
|
+$19M |
| 5 |
CME Group
CME
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.65% |
| 2 | Consumer Discretionary | 16.65% |
| 3 | Healthcare | 13.39% |
| 4 | Financials | 10.04% |
| 5 | Industrials | 8.19% |
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q1 2023 Portfolio in Review
As of Q1 2023, Castleark Management held 334 positions worth $2.04B, up 6.3% from $1.91B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Castleark Management's Q1 2023 filing shows 52 new, 46 increased, 60 reduced and 62 closed positions. Its largest new stake was State Street Industrial Select Sector SPDR ETF: 447,010 shares worth $45.2M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $37.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Castleark Management's largest Q1 2023 buy was State Street Industrial Select Sector SPDR ETF: 447,010 shares worth $45.2M.
- Castleark Management added most to iShares MSCI EAFE ETF in Q1 2023, an estimated $23.9M increase.
- Castleark Management's biggest Q1 2023 reduction was Charles Schwab, cutting an estimated $21.8M.
- Castleark Management fully exited State Street SPDR S&P Biotech ETF in Q1 2023, selling an estimated $37.2M.
- Castleark Management's ten largest holdings make up 32% of its $2.04B portfolio in Q1 2023.
- Castleark Management opened 52 new positions and closed 62 in Q1 2023.
- Castleark Management's portfolio value rose 6.3% quarter-over-quarter to $2.04B.
Based on Castleark Management's 13F filing for Q1 2023, filed 16 May 2023.